                </a></li></ul></div><p><strong>Figure 3.  <span>Tumor-free survival, tumor spectrum and tumor incidence of <em>R26-Pten<sup>fx/fx</sup></em> mice.</span></strong></p><a id="article1.body1.sec2.sec2.fig1.caption1.p1" name="article1.body1.sec2.sec2.fig1.caption1.p1"></a><p>(A) Tumor-free survival of <em>Pten<sup>fx/fx</sup></em>, <em>R26-Pten<sup>fx/+</sup></em> and <em>R26-Pten<sup>fx/fx</sup></em> mice; (B) Tumor-free survival of male and female <em>R26-Pten<sup>fx/fx</sup></em> mice; (C) Tumor spectrum and incidence of male and female <em>R26-Pten<sup>fx/fx</sup></em> mice; Lym, lymphomas; PC, prostate cancer; EC, endometrial cancer; IC, intestinal cancer; SCC, squamous cell carcinoma; The percentage of each tumor type is shown on the right of bar graph. (D) Tumor latency of the <em>R26-Pten<sup>fx/fx</sup></em> mice; each dot represents an individual malignant tumor in the <em>R26-Pten<sup>fx/fx</sup></em> mice. ⧫, Lymphoma (Lym); ▪, Squamous cell carcinoma (SCC); ▴, Intestinal cancer (IC); •, prostate cancer (PC); Bars represent the mean tumor latency.</p>
